130 related articles for article (PubMed ID: 27100344)
1. Anticancer activity of drug conjugates in head and neck cancer cells.
Majumdar D; Rahman MA; Chen ZG; Shin DM
Front Biosci (Elite Ed); 2016 Jun; 8(3):358-69. PubMed ID: 27100344
[TBL] [Abstract][Full Text] [Related]
2. Water-soluble polymers for targeted drug delivery to human squamous carcinoma of head and neck.
Nan A; Ghandehari H; Hebert C; Siavash H; Nikitakis N; Reynolds M; Sauk JJ
J Drug Target; 2005 Apr; 13(3):189-97. PubMed ID: 16036307
[TBL] [Abstract][Full Text] [Related]
3. p16, HPV, and Cetuximab: What Is the Evidence?
Bonner JA; Mesia R; Giralt J; Psyrri A; Keilholz U; Rosenthal DI; Beier F; Schulten J; Vermorken JB
Oncologist; 2017 Jul; 22(7):811-822. PubMed ID: 28526718
[TBL] [Abstract][Full Text] [Related]
4. Impact of human papilloma virus infection on the response of head and neck cancers to anti-epidermal growth factor receptor antibody therapy.
Pogorzelski M; Ting S; Gauler TC; Breitenbuecher F; Vossebein I; Hoffarth S; Markowetz J; Lang S; Bergmann C; Brandau S; Jawad JA; Schmid KW; Schuler M; Kasper S
Cell Death Dis; 2014 Feb; 5(2):e1091. PubMed ID: 24577089
[TBL] [Abstract][Full Text] [Related]
5. Feasibility and pharmacokinetics of paclitaxel, carboplatin, and concurrent radiotherapy for regionally advanced squamous cell carcinoma of the head and neck and for regionally advanced non-small cell lung cancer.
Aisner J; Belani CP; Kearns C; Conley B; Hiponia D; Engstrom C; Zuhowski E; Egorin MJ
Semin Oncol; 1995 Oct; 22(5 Suppl 12):17-21. PubMed ID: 7481856
[TBL] [Abstract][Full Text] [Related]
6. [Relationship between human papilloma virus infection and expression of p16 and EGFR in head and neck squamous cell carcinoma and their prognostic significance].
Ma L; Wang D; Wufuer A; Wu R; Zhang S; Wang R
Zhonghua Zhong Liu Za Zhi; 2014 Jan; 36(1):23-8. PubMed ID: 24685082
[TBL] [Abstract][Full Text] [Related]
7. Durable complete response induced by paclitaxel-nimotuzumab-methotrexate chemotherapy in a patient with metastatic head and neck squamous cell carcinoma.
Verduzco-Rodríguez L; Aguirre-González EH; Verduzco-Aguirre HC
Hematol Oncol Stem Cell Ther; 2011; 4(4):182-4. PubMed ID: 22198189
[TBL] [Abstract][Full Text] [Related]
8. Paclitaxel enhances in vitro radiosensitivity of squamous carcinoma cell lines of the head and neck.
Leonard CE; Chan DC; Chou TC; Kumar R; Bunn PA
Cancer Res; 1996 Nov; 56(22):5198-204. PubMed ID: 8912857
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapeutic alteration of VEGF-/PDGF- and PDGF-Rα/β expression by imatinib in HPV-transformed squamous cell carcinoma compared to HPV-negative HNSCC in vitro.
Schultz JD; Mühlheim K; Erben P; Hofheinz RD; Faber A; Thorn C; Sommer JU; Hörmann K; Sauter A
Oncol Rep; 2011 Nov; 26(5):1099-109. PubMed ID: 21805039
[TBL] [Abstract][Full Text] [Related]
10. Antitumor activity of human papillomavirus type 16 E7-specific T cells against virally infected squamous cell carcinoma of the head and neck.
Albers A; Abe K; Hunt J; Wang J; Lopez-Albaitero A; Schaefer C; Gooding W; Whiteside TL; Ferrone S; DeLeo A; Ferris RL
Cancer Res; 2005 Dec; 65(23):11146-55. PubMed ID: 16322265
[TBL] [Abstract][Full Text] [Related]
11. Targeting pathways mediating resistance to anti-EGFR therapy in squamous cell carcinoma of the head and neck.
Campbell NP; Hensing TA; Bhayani MK; Shaikh AY; Brockstein BE
Expert Rev Anticancer Ther; 2016 Aug; 16(8):847-58. PubMed ID: 27400139
[TBL] [Abstract][Full Text] [Related]
12. DETECTION OF HUMAN PAPILLOMA VIRUS IN HEAD AND NECK SQUAMOUS CELL CARCINOMAS: A LITERATURE REVIEW.
Jelihovschi I; Bidescu AC; Tucaliuc SE; Iancu LS
Rev Med Chir Soc Med Nat Iasi; 2015; 119(2):502-9. PubMed ID: 26204659
[TBL] [Abstract][Full Text] [Related]
13. Polymersome-mediated delivery of combination anticancer therapy to head and neck cancer cells: 2D and 3D in vitro evaluation.
Colley HE; Hearnden V; Avila-Olias M; Cecchin D; Canton I; Madsen J; MacNeil S; Warren N; Hu K; McKeating JA; Armes SP; Murdoch C; Thornhill MH; Battaglia G
Mol Pharm; 2014 Apr; 11(4):1176-88. PubMed ID: 24533501
[TBL] [Abstract][Full Text] [Related]
14. Cetuximab therapy in head and neck cancer: immune modulation with interleukin-12 and other natural killer cell-activating cytokines.
Luedke E; Jaime-Ramirez AC; Bhave N; Roda J; Choudhary MM; Kumar B; Teknos TN; Carson WE
Surgery; 2012 Sep; 152(3):431-40. PubMed ID: 22770960
[TBL] [Abstract][Full Text] [Related]
15. Use of paclitaxel (Taxol) in squamous cell carcinoma of the head and neck.
Forastiere AA
Semin Oncol; 1993 Aug; 20(4 Suppl 3):56-60. PubMed ID: 8102018
[TBL] [Abstract][Full Text] [Related]
16. Improved clearance during treatment of HPV-positive head and neck cancer through mTOR inhibition.
Coppock JD; Wieking BG; Molinolo AA; Gutkind JS; Miskimins WK; Lee JH
Neoplasia; 2013 Jun; 15(6):620-30. PubMed ID: 23730210
[TBL] [Abstract][Full Text] [Related]
17. Decreased SMAD4 expression is associated with induction of epithelial-to-mesenchymal transition and cetuximab resistance in head and neck squamous cell carcinoma.
Cheng H; Fertig EJ; Ozawa H; Hatakeyama H; Howard JD; Perez J; Considine M; Thakar M; Ranaweera R; Krigsfeld G; Chung CH
Cancer Biol Ther; 2015; 16(8):1252-8. PubMed ID: 26046389
[TBL] [Abstract][Full Text] [Related]
18. Oral sex and human papilloma virus-related head and neck squamous cell cancer: a review of the literature.
Shah A; Malik A; Garg A; Mair M; Nair S; Chaturvedi P
Postgrad Med J; 2017 Nov; 93(1105):704-709. PubMed ID: 28778951
[TBL] [Abstract][Full Text] [Related]
19. Early investigational drugs that target epidermal growth factor receptors for the treatment of head and neck cancer.
Ugurluer G; Ozsahin M
Expert Opin Investig Drugs; 2014 Dec; 23(12):1637-54. PubMed ID: 25134724
[TBL] [Abstract][Full Text] [Related]
20. Exploring the implications of HPV infection for head and neck cancer.
Field N; Lechner M
Sex Transm Infect; 2015 Jun; 91(4):229-30. PubMed ID: 25904746
[No Abstract] [Full Text] [Related]
[Next] [New Search]
